Reinhardt has been with the Raynham, Mass.-based medical device company since 2002, according to a press release.
Nawana stepped down abruptly Nov. 27 after less than a year on the job.
Orthopedics This Week reported that Reinhardt would succeed Nawana when the latter stepped down.
The executive shuffle comes amid tough times for the spinal products business. Global sales for the division were down 3% on an operational basis and U.S. sales were down approximately 6% during the last quarter, according to the website.
J&J in June paid $19.7 billion for the Swiss orthopedics giant to form the DePuy Synthes Cos. of Johnson & Johnson.
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.